167 related articles for article (PubMed ID: 25116973)
1. Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part I.
Walls B; Jordan L; Diaz L; Miller R
J Drugs Dermatol; 2014 Aug; 13(8):947-52. PubMed ID: 25116973
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part II.
Walls B; Jordan L; Diaz L; Miller R
J Drugs Dermatol; 2014 Aug; 13(8):955-8. PubMed ID: 25116974
[TBL] [Abstract][Full Text] [Related]
3. Non-Melanoma Skin Cancers: Biological and Clinical Features.
Cives M; Mannavola F; Lospalluti L; Sergi MC; Cazzato G; Filoni E; Cavallo F; Giudice G; Stucci LS; Porta C; Tucci M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751327
[TBL] [Abstract][Full Text] [Related]
4. Changing pathology with changing drugs: skin cancer.
Karpova MB; Barysch MJ; Zipser MC; Schönewolf N; French LE; Dummer R
Pathobiology; 2011; 78(2):61-75. PubMed ID: 21677470
[TBL] [Abstract][Full Text] [Related]
5. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
[TBL] [Abstract][Full Text] [Related]
6. Update of cetuximab for non-melanoma skin cancer.
Wollina U
Expert Opin Biol Ther; 2014 Feb; 14(2):271-6. PubMed ID: 24387664
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
Kudchadkar R; Lewis K; Gonzalez R
Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
[TBL] [Abstract][Full Text] [Related]
8. Review of Targeted Therapies for Periocular Tumors.
Mehta VJ; Ling J; Sobel RK
Int Ophthalmol Clin; 2017; 57(1):153-168. PubMed ID: 27898621
[No Abstract] [Full Text] [Related]
9. Pharmacologic treatment options for advanced epithelial skin cancer.
Soura E; Chasapi V; Stratigos AJ
Expert Opin Pharmacother; 2015; 16(10):1479-93. PubMed ID: 26027692
[TBL] [Abstract][Full Text] [Related]
10. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Rudnick EW; Thareja S; Cherpelis B
Int J Dermatol; 2016 Mar; 55(3):249-58; quiz 256, 258. PubMed ID: 26566923
[TBL] [Abstract][Full Text] [Related]
11. Update on the Use and Treatment of Targeted Molecular Inhibitors for Locally Advanced and Metastatic Non-Melanoma Skin Cancers.
Odueyungbo M; Ratner D
Dermatol Surg; 2016 Jan; 42 Suppl 1():S49-56. PubMed ID: 26730974
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy].
Reifenberger J; Schön MP
Hautarzt; 2003 Dec; 54(12):1164-70. PubMed ID: 14634745
[TBL] [Abstract][Full Text] [Related]
13. Progress in cutaneous cancer research.
Dlugosz A; Merlino G; Yuspa SH
J Investig Dermatol Symp Proc; 2002 Dec; 7(1):17-26. PubMed ID: 12518788
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC.
Ali FR; Lear JT
Br J Dermatol; 2013 Jul; 169(1):53-7. PubMed ID: 23488543
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
Walls B
Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
[No Abstract] [Full Text] [Related]
16. Molecularly targeted therapies for nonmelanoma skin cancers.
Liu LS; Colegio OR
Int J Dermatol; 2013 Jun; 52(6):654-65. PubMed ID: 23679874
[TBL] [Abstract][Full Text] [Related]
17. [Photochemical internalisation (PCI): a further development of photodynamic therapy for the treatment of skin cancer].
Johansen P; Berg K; Selbo PK; Hofbauer GF
Praxis (Bern 1994); 2010 Nov; 99(23):1423-8. PubMed ID: 21082595
[TBL] [Abstract][Full Text] [Related]
18. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
Cirrone F; Harris CS
Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
[TBL] [Abstract][Full Text] [Related]
19. Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib.
Iarrobino A; Messina JL; Kudchadkar R; Sondak VK
J Am Acad Dermatol; 2013 Jul; 69(1):e33-4. PubMed ID: 23768306
[No Abstract] [Full Text] [Related]
20. [Vismodegib in metastasized basal cell carcinoma].
Reinders MG; Dirix L; Mosterd K; van Doorn R
Ned Tijdschr Geneeskd; 2013; 157(12):A6011. PubMed ID: 23515044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
